FindTrial
Sign In

Analysis of Dog-Assisted Physiotherapy for children with Cerebral Palsy

Dog-Assisted Physiotherapy: structured complementary physiotherapeutic intervention in children with Cerebral Palsy: a single-subject design

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-69mywb5
Enrollment
Unknown
Registered
2023-05-25
Start date
2023-02-01
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cerebral Palsy

Interventions

This is a Single-Subject Design clinical trial, using the A1BA2 model design, in three research phases: baseline (A1), 12 intervention sessions based on Dog-Assisted Physiotherapy (B) and a second pha
E02.831.535.179

Sponsors

Departamento de Ciências do Movimento Humano - Universidade Federal de São Paulo
Lead Sponsor
Unifesp - Universidade Federal de São Paulo
Collaborator

Eligibility

Age
6 Years to 10 Years

Inclusion criteria

Inclusion criteria: Children diagnosed with Cerebral Palsy with unilateral or bilateral involvement; both genders; age between 6 and 10 years; classified by the Gross Motor Function Classification System - GMFCS, at levels II or III; having already had contact with dogs in the home, family, friends or neighborhood; being part of a physiotherapy service; do not have surgeries scheduled for the six months following the beginning of the research

Exclusion criteria

Exclusion criteria: Two consecutive or alternating fouls per phase; signs of aversion to the dog or the therapy; dog allergy signs

Design outcomes

Primary

MeasureTime frame
Evaluate significant clinical alterations, in the period of 14 weeks, measured by the instruments Gross Motor Function Measure, GMFM; Participation and Environment Measure, Children and Young People, PEM-CY; Pediatric Reach Test; Timed Up and Go Test, TUG; 10 meter Walk Test, TC10m; verified by A1BA2 type design, with a minimum of five evaluation moments in each phase, as well as improvement in activity and participation in phase A2, according to the summarized core-set parameters of the ICF—

Secondary

MeasureTime frame
It is expected to find improvement in the activity and participation of children according to ICF parameters, with significantly clinical changes measured by standardized instruments, in a minimum period of 14 weeks, through the A1BA2 type design, with a minimum of five evaluation moments in each phase, in patients with CP, between 6 and 10 years, GMFCS II or III—

Countries

Brazil

Contacts

Public ContactAnice Maria Nascimento

Unifesp - Universidade Federal de São Paulo

amcnascimento@unifesp.br+5519971720105

Outcome results

None listed

Source: REBEC (via WHO ICTRP)